Stonebridge Capital Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-300
Closed -$8.22K 975
2023
Q1
$8.22K Hold
300
﹤0.01% 636
2022
Q4
$8.38K Sell
300
-100
-25% -$3.02K ﹤0.01% 627
2022
Q3
$12K Hold
400
﹤0.01% 545
2022
Q2
$11K Sell
400
-100
-20% -$2.85K ﹤0.01% 581
2022
Q1
$16K Hold
500
﹤0.01% 572
2021
Q4
$15K Hold
500
﹤0.01% 566
2021
Q3
$15K Sell
500
-900
-64% -$31K ﹤0.01% 553
2021
Q2
$51K Buy
1,400
+700
+100% +$26K ﹤0.01% 465
2021
Q1
$26K Buy
+700
New +$25.8K ﹤0.01% 457
2020
Q3
Sell
-1,100
Closed -$33K 535
2020
Q2
$33K Hold
1,100
0.01% 331
2020
Q1
$29K Hold
1,100
0.01% 326
2019
Q4
$47K Hold
1,100
0.01% 330
2019
Q3
$46K Hold
1,100
0.01% 331
2019
Q2
$40K Buy
+1,100
New +$40.1K 0.01% 355

Other funds holding OHI

Stonebridge Capital Advisors's OHI Position: Q2 2023 in Review

Stonebridge Capital Advisors sold out of Omega Healthcare (OHI) in Q2 2023, closing a stake of 300 shares — an estimated $8.22K sold.

Stonebridge Capital Advisors first reported a position in OHI in Q2 2019 and held it in 14 quarters. The position peaked at $51K in Q2 2021. 510 funds tracked by Wall St. Rank hold OHI as of Q2 2023.

  • Stonebridge Capital Advisors reported no remaining Omega Healthcare position as of Q2 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 300 Omega Healthcare shares in Q2 2023, an estimated $8.22K.
  • Stonebridge Capital Advisors first reported a position in Omega Healthcare in Q2 2019 and held it in 14 quarters.
  • Stonebridge Capital Advisors's Omega Healthcare position peaked at $51K in Q2 2021.
  • 510 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2023, filed 23 Aug 2023.